3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Gastrointestinal
1
CNS
1
Conditions
Brain Neoplasms
12
Supratentorial Neoplasms
2
Meningioma
2
Delirium
2
Stroke
1
Spinal Cord Neoplasms
1
Seizures
1
Pain, Postoperative
1
Pain
1
Neuroinflammatory Diseases
1
Neurofibromatosis 1
1
Neurocognitive Disorders
1
Neoplasms
1
Hypoxia
1
Hemorrhage
1
Glioma
1
Glioblastoma
1
Epilepsy
1
Emergence Delirium
1
Central Nervous System Vascular Malformations
1
Central Nervous System Diseases
1
Arteriovenous Malformations
1
Aneurysm
1
Interventions
Oxycodone
2
Methadone
2
Fentanyl
2
Analgesia
2
Acupuncture Therapy
2
ziprasidone
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Uncertainty
1
Tranexamic Acid
1
Tobramycin
1
Spironolactone
1
Sevelamer
1
Saline Solution
1
Rocuronium
1
Remifentanil
1
Psychosocial Intervention
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Nifedipine
1
Nafcillin
1
Morphine
1
Molindone
1
Methylprednisolone
1
Lurasidone Hydrochloride
1
Labetalol
1
Haloperidol
1
Gelclair
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pain
×
Saline Solution
×
CNS
×
Clear all
NCT07398066
2026-02-09
DEX-NEURO
University of Malaya
Phase NA
Not yet recruiting
60 enrolled